ProShares UltraShort Nasdaq Biotechnology (BIS) News Today → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free BIS Stock Alerts $20.90 -0.08 (-0.38%) (As of 05:36 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartDividendHoldingsOptions ChainOwnershipShort InterestSocial MediaStock AnalysisChartDividendHoldingsOptions ChainOwnershipShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineShort Interest in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Expands By 144.3%americanbankingnews.com - April 13 at 5:18 AMCompare with ProShares Ultra Nasdaq Biotechnology (BIB)msn.com - March 31 at 7:48 PMUltraShort Nasdaq Biotechnology declares quarterly distribution of $0.1586msn.com - March 22 at 7:48 PMProShares UltraShort Nasdaq Biotechnology (BIS)investing.com - January 31 at 2:09 AMProShares UltraPro QQQ (NASDAQ:TQQQ), Short Interest Reportbenzinga.com - October 1 at 10:40 PMProFunds UltraShort NASDAQ-100 Svcmorningstar.com - May 13 at 8:05 AMTrading Proshares Ultrashort S&p500 $SDS With Integrated Risk Controlsmarketwatch.com - May 9 at 12:38 AMProFunds UltraShort NASDAQ-100 Invmorningstar.com - March 12 at 11:39 PMTrinity Biotech Stock (NASDAQ:TRIB), Quotes and News Summarybenzinga.com - January 29 at 12:20 AMNASDAQ Biotechnology Index .NBI : NASDAQcnbc.com - January 26 at 7:10 PMBIB ProShares Trust - ProShares Ultra Nasdaq Biotechnologyseekingalpha.com - November 12 at 9:48 PMFive Myths about Nasdaq Indexesnasdaq.com - September 19 at 5:44 PMAllergan, Tesla and iShares Nasdaq Biotechnology: Doug Kass' Viewsthestreet.com - September 14 at 4:44 PMProShares Trust - ProShares UltraShort Nasdaq Biotechnology -2x Sharesmoney.usnews.com - July 20 at 3:37 AMProShares Trust - ProShares UltraShort Nasdaq Biotechnologymoney.usnews.com - February 14 at 9:41 PMBiotech Bumble: ETFs Fall to 2014 Lowsfinance.yahoo.com - October 27 at 12:25 AM Get ProShares UltraShort Nasdaq Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for BIS and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. BIS Media Mentions By Week BIS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIS News Sentiment▼1.110.53▲Average News Sentiment BIS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIS Articles This Week▼10▲BIS Articles Average Week Get ProShares UltraShort Nasdaq Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for BIS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Invesco Nasdaq Biotechnology ETF News Today Principal Healthcare Innovators ETF News Today ProShares Ultra Nasdaq Biotechnology News Today Invesco S&P SmallCap Health Care ETF News Today VanEck Biotech ETF News Today VanEck Pharmaceutical ETF News Today iShares Biotechnology ETF News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIS) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares UltraShort Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.